Protocol Complexity in Clinical Trials: Impact on Study Success

Protocol complexity in clinical trials is increasing and it’s becoming a major barrier to study success.

More procedures, more endpoints, and more data may strengthen a study on paper. But in practice, they can slow enrollment, strain sites, and make participation harder for patients.

For sponsors and clinical operations teams, the challenge is no longer just designing a scientifically sound study. It’s designing one that is feasible, efficient, and patient-centered.

What Is Protocol Complexity in Clinical Trials?

Protocol complexity refers to the scope and intensity of requirements within a clinical trial design.

This includes:

• Number of study visits and procedures
• Volume and type of data collected
• Number of endpoints
• Eligibility criteria

Individually, these elements may seem manageable. Together, they can create operational strain across sites and increase burden for patients.

Why Protocol Complexity in Clinical Trials Impacts Study Success

Impact on Clinical Trial Sites

Clinical trial sites are responsible for executing the protocol and they often feel the strain first.

As complexity increases, so do:

• Administrative and regulatory demands
• Data entry requirements
• Training needs and resource constraints

 In some cases, experienced, high-enrolling sites may choose not to participate at all if a study is too complex.

For those that do participate, the result is often:

• Slower enrollment
• Increased protocol deviations and amendments
• Operational inefficiencies

Because a trial is only as successful as its sites, this has direct implications for study outcomes.

Impact on Patient Recruitment and Retention

Protocol complexity also directly affects patient recruitment and retention, two of the most critical drivers of trial success.

Patient burden is shaped by study design — frequent visits, invasive procedures, and travel requirements all add up.

The result:

• Lower enrollment rates
• Higher screen failure rates
• Increased dropout

More data does not always mean better outcomes, especially if patients cannot realistically complete the study.

How to Reduce Protocol Complexity in Practice

Reducing protocol complexity doesn’t mean sacrificing scientific rigor. It means being intentional about design.

Here are practical ways sponsors and CROs can improve protocol complexity:

• Pressure-test every procedure
  Ask: Is this essential to the study objective?
• Engage sites early
  Gather feasibility input from experienced sites before finalizing the protocol
• Incorporate patient-centric design
  Use patient feedback to understand real-world burden
• Leverage decentralized clinical trial (DCT) elements
  Reduce travel and make participation more accessible
• Review historical trial data and benchmarking
  Identify patterns that lead to delays, amendments, or enrollment challenges
• Simplify visit schedules where possible
  Focus on what is necessary, not what is possible

Small design decisions made early can have a significant downstream impact on timelines, cost, and success.

Using Data and Benchmarking to Reduce Protocol Complexity

There is growing interest in using clinical trial analytics and benchmarking to better understand and reduce protocol complexity.

In practice, this typically involves using data platforms that aggregate historical clinical trial data, either from a sponsor’s past studies or from industry benchmarks. These platforms analyze patterns across studies to show what has worked well and where challenges tend to arise.

For example, sponsors can use this data to identify:

• Which protocol elements (such as number of endpoints or procedures) are associated with higher amendment rates
• Where enrollment slowdowns commonly occur, based on similar study designs or indications
• How visit schedules compare to industry norms, and where they may be overly burdensome for sites or patients

Benchmarking allows teams to compare their protocol design against similar trials, helping them spot potential risks early and make more informed decisions before the study begins.

Advanced analytics builds on this by using statistical models to identify patterns and predict potential challenges, such as which sites may enroll more slowly or which study designs may increase the likelihood of amendments. These insights are typically directional, helping teams ask better questions rather than providing definitive answers.

AI is beginning to play a role as well, though its use is still emerging. In this context, AI is often used to:

• Analyze large volumes of structured and unstructured data (such as past protocols or site performance data)
• Identify patterns that may not be immediately obvious through manual review
• Simulate “what-if” scenarios, such as how reducing the number of visits or simplifying eligibility criteria might impact timelines or patient burden

Importantly, these tools are meant to support, not replace, clinical and operational expertise. Their value lies in surfacing insights and trade-offs earlier in the design process, so teams can make more informed, experience-backed decisions.

However, adoption is still evolving, particularly given considerations around data privacy, confidentiality of study design, and real-world implementation.

For now, many organizations are focusing on combining data-driven insights with operational expertise to guide smarter protocol design.

The Compounding Effect of Complexity

Protocol complexity doesn’t operate in isolation.

• Increased site burden slows operations
• Increased patient burden reduces participation
• Together, they extend timelines and increase costs

Even incremental increases in complexity can have a measurable impact on clinical trial timelines and study success. Sometimes making small research study design changes can be impactful.

Finding the Right Balance

The goal isn’t to simplify for the sake of simplicity. It’s to design smarter.

A successful protocol balances:

• Scientific rigor
• Operational feasibility
• Patient experience

When that balance is achieved, trials are more efficient, more accessible, and more likely to meet their objectives.